First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2004-05-20 15:01:10Open Document File Size: 732,48 KBShare Result on FacebookCityCambridge / Reid / /CompanyJ. S. and Lipton S. A. / AstraZeneca Canada / MCA / Emery A. E. / D. S. and Becker L. C. / /CountryUnited States / Canada / United Kingdom / / /FacilitynNOS complex / Bidder Building / University of California / /IndustryTermprinting / online version / Web Electronic copies / /MedicalConditionmuscular dystrophy / hypertension / human muscular dystrophy / cerebral ischemia / ischemic stroke / clinically important neurological diseases / contraction / certain muscular dystrophies / injury / Reduced brain edema / synaptic depression / muscular dystrophies / long-term synaptic depression / /OrganizationHealth Research/Heart and Stroke Foundation / David S. Bredt* Department of Physiology / American Heart Association / University of California at San Francisco School of Medicine / /PersonImran N. Mungrue / David S. Bredt / /PositionExecutive Editor at the address below / *Author / /ProductDexamethasone / /ProvinceOrStateM. B. / /Technologyalpha / Genomics / Neuroscience / JPEG / Cav / /URLhttp /SocialTag |